India Economy Thread

Indian Rupee hits record low, experts predict it will fall further | The World | ABC News​

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Rupee Slides to 91.48/USD Amid West Asia Tensions | Worst Performing Asian Currency | Business News​

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.


1 CNY ≈ 12.7215 INR
 
Last edited:
Cheaper rupee means your exports become cheaper, so Indians may not exactly be sad about this. China and many East Asian export-based economies also keep their currency artificially low.
 
To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Vizag is a beauty !! Also have good influx of people from different part of india. A good alternative to Bangalore and Hyderabad.
 

India’s biologics dream hits Chinese wall​

TNN / Apr 01, 2026, 06:15 IST

NEW DELHI: Indian firms hoping to ride the global biologics boom are finding the path far tougher than expected, as China tightens its grip further on biotech supply chains. Recent data suggests Chinese companies have bagged more than half of several recent project deals from US biotech companies, underscoring the challenge for Indian players trying to break into complex biologics.

Unlike generics, where India leveraged cost efficiency and scale to capture global markets, biologics demand deep R&D capabilities, sophisticated manufacturing infrastructure and specialised talent, raising both entry barriers and financial risks, analysts say.

toi-infograf.jpg


Over the last few years, China has rapidly emerged as a major force in biotech, with biologics accounting for about 42% of its new drug approvals in 2023, up from 9% in 2015, cementing its position in global supply chains for complex niche biologics. Against this backdrop, Indian companies will need to recalibrate strategy if they are to carve out a meaningful share in advanced therapies.

K V Subramaniam, president, Reliance Life Sciences, said: “In last seven years, China has come from behind and forged way ahead of India in biopharmaceuticals, driven by mission-driven govt policy, fast-track regulatory approvals and clearance of a huge drug approval backlog.”

“Recent project flows suggest Chinese companies have been able to secure more than half of their new orders from US-biotech companies, indicating Chinese companies’ operational scale, cost competitiveness and established capabilities remain unmatched,’’ said Tausif Shaikh, India analyst pharma and healthcare at BNP Paribas.
 

Fuel Panic Across India | Long Queues, Pumps Dry As Govt Denies Shortage | Energy Crisis​

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.


India's energy crisis stems from profound strategic short-sightedness and greed. While New Delhi profited from discounted Russian oil, it foolishly avoided long-term contracts to maximize immediate arbitrage gains. This lack of foresight left the nation exposed.

Compounding this error, Prime Minister Modi’s ill-timed visit to Israel on the eve of war antagonized key regional players. When conflict erupted and the Strait of Hormuz closed, India's supply lines were severed. By prioritizing quick profits over energy security, New Delhi has engineered a self-inflicted economic disaster.
 
Last edited:

Users who are viewing this thread

Pakistan Defence Latest

Country Watch Latest

Back
Top